Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10018200 | Annals of Emergency Medicine | 2005 | 10 Pages |
Abstract
Active surveillance for outpatient adverse drug events using the National Electronic Injury Surveillance System-All Injury Program is feasible. Ongoing, population-based ED surveillance can help characterize the burden of outpatient adverse drug events, prioritize areas for further research and intervention, and monitor progress on adverse drug event prevention.
Related Topics
Health Sciences
Medicine and Dentistry
Emergency Medicine
Authors
Daniel S. MD, MPH, Daniel A. MD, Aaron B. PhD, MPH, Kelly N. BS, Arthur K. MPhil, Joseph L. PhD,